Preface

Alzheimer’s Disease (AD), a progressive neurodegenerative disorder, represents one of the most formidable challenges in contemporary medicine and neuroscience. As global populations age, the incidence of Alzheimer’s continues to rise, exerting profound social, economic, and healthcare burdens across the world. This book, Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics, provides a comprehensive and multidisciplinary overview of the latest advancements in our understanding, diagnosis, and treatment of Alzheimer’s disease. The book begins by exploring the historical background, epidemiology, and global impact of Alzheimer’s Disease, laying the foundation for a deeper understanding of its pathophysiology. A thorough examination of the molecular and cellular mechanisms underpinning Alzheimer’s progression is presented, followed by insights into biomarkers and their emerging role in early detection and therapeutic targeting.

Technological progress has redefined diagnostic approaches, and the book highlights the growing utility of neuroimaging techniques and digital tools, including artificial intelligence, in enhancing diagnostic precision. In addition, a significant portion is dedicated to natural products, phytochemicals, immunotherapies, gene therapy, and RNA-based innovations, showcasing novel therapeutic frontiers. Recognizing the multifactorial nature of Alzheimer’s, chapters also delve into comorbid conditions that influence disease progression, as well as the latest developments in pharmacological treatments and intranasal drug delivery strategies. The inclusion of case studies and patents further connects theoretical advancements with real-world applications, offering a well-rounded perspective on ongoing innovation in the field.

Technological progress has redefined diagnostic approaches, and the book highlights the growing utility of neuroimaging techniques and digital tools, including artificial intelligence, in enhancing diagnostic precision. In addition, a significant portion is dedicated to natural products, phytochemicals, immunotherapies, gene therapy, and RNA-based innovations, showcasing novel therapeutic frontiers. Recognizing the multifactorial nature of Alzheimer’s, chapters also delve into comorbid conditions that influence disease progression, as well as the latest developments in pharmacological treatments and intranasal drug delivery strategies. The inclusion of case studies and patents further connects theoretical advancements with real-world applications, offering a well-rounded perspective on ongoing innovation in the field.

This volume brings together contributions from experts across diverse disciplines, making it a valuable resource for clinicians, researchers, students, and pharmaceutical professionals. It aims not only to consolidate current knowledge but also to inspire future research directions and therapeutic breakthroughs.

We trust that this book will serve as a valuable guide in your exploration of Alzheimer’s disease and stimulate continued inquiry into innovative solutions for this pressing global health issue.